{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,6,27]],"date-time":"2026-06-27T14:29:33Z","timestamp":1782570573144,"version":"3.54.5"},"reference-count":39,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2025,5,1]],"date-time":"2025-05-01T00:00:00Z","timestamp":1746057600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2025,5,1]],"date-time":"2025-05-01T00:00:00Z","timestamp":1746057600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2025,5,1]],"date-time":"2025-05-01T00:00:00Z","timestamp":1746057600000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-017"},{"start":{"date-parts":[[2025,5,1]],"date-time":"2025-05-01T00:00:00Z","timestamp":1746057600000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-037"},{"start":{"date-parts":[[2025,5,1]],"date-time":"2025-05-01T00:00:00Z","timestamp":1746057600000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-012"},{"start":{"date-parts":[[2025,5,1]],"date-time":"2025-05-01T00:00:00Z","timestamp":1746057600000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-029"},{"start":{"date-parts":[[2025,5,1]],"date-time":"2025-05-01T00:00:00Z","timestamp":1746057600000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-004"}],"funder":[{"DOI":"10.13039\/501100012166","name":"National Key Research and Development Program of China","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100012166","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100013290","name":"National Key Research and Development Program of China Stem Cell and Translational Research","doi-asserted-by":"publisher","award":["2019YFA0110601"],"award-info":[{"award-number":["2019YFA0110601"]}],"id":[{"id":"10.13039\/501100013290","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["clinicalkey.fr","clinicalkey.jp","clinicalkey.com.au","thrombosisresearch.com","clinicalkey.es","clinicalkey.com","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Thrombosis Research"],"published-print":{"date-parts":[[2025,5]]},"DOI":"10.1016\/j.thromres.2025.109302","type":"journal-article","created":{"date-parts":[[2025,3,8]],"date-time":"2025-03-08T23:52:25Z","timestamp":1741477945000},"page":"109302","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":4,"special_numbering":"C","title":["Efficacy and safety of antithrombin or recombinant human thrombomodulin in the treatment of disseminated intravascular coagulation: A systematic review and meta-analysis"],"prefix":"10.1016","volume":"249","author":[{"given":"Wenchi","family":"Li","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Shuyue","family":"Sheng","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Feng","family":"Zhu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.thromres.2025.109302_bb0005","doi-asserted-by":"crossref","first-page":"1327","DOI":"10.1055\/s-0037-1616068","article-title":"Towards definition, clinical and laboratory criteria, and a scoring system for disseminated intravascular coagulation","volume":"86","author":"Taylor","year":"2001","journal-title":"Thromb. Haemost."},{"key":"10.1016\/j.thromres.2025.109302_bb0010","doi-asserted-by":"crossref","first-page":"13","DOI":"10.1016\/j.cccn.2004.02.015","article-title":"Disseminated intravascular coagulation","volume":"344","author":"Wada","year":"2004","journal-title":"Clin. Chim. Acta"},{"key":"10.1016\/j.thromres.2025.109302_bb0015","doi-asserted-by":"crossref","DOI":"10.1002\/ams2.659","article-title":"The Japanese Clinical Practice Guidelines for Management of Sepsis and Septic Shock 2020 (J-SSCG 2020)","volume":"8","author":"Egi","year":"2021","journal-title":"Acute Med Surg"},{"key":"10.1016\/j.thromres.2025.109302_bb0020","doi-asserted-by":"crossref","first-page":"743","DOI":"10.1007\/s12185-019-02740-9","article-title":"Supportive care for hemostatic complications associated with pediatric leukemia: a national survey in Japan","volume":"110","author":"Osone","year":"2019","journal-title":"Int. J. Hematol."},{"key":"10.1016\/j.thromres.2025.109302_bb0025","doi-asserted-by":"crossref","first-page":"253","DOI":"10.1007\/s12185-015-1904-z","article-title":"Present and future of anticoagulant therapy using antithrombin and thrombomodulin for sepsis-associated disseminated intravascular coagulation: a perspective from Japan","volume":"103","author":"Iba","year":"2016","journal-title":"Int. J. Hematol."},{"key":"10.1016\/j.thromres.2025.109302_bb0030","doi-asserted-by":"crossref","first-page":"874","DOI":"10.1177\/1076029618757346","article-title":"Optimal antithrombin activity threshold for initiating antithrombin supplementation in patients with sepsis-induced disseminated intravascular coagulation: a multicenter retrospective observational study","volume":"24","author":"Hayakawa","year":"2018","journal-title":"Clin. Appl. Thromb. Hemost."},{"key":"10.1016\/j.thromres.2025.109302_bb0035","doi-asserted-by":"crossref","first-page":"90","DOI":"10.1111\/j.1538-7836.2005.01697.x","article-title":"Treatment effects of high-dose antithrombin without concomitant heparin in patients with severe sepsis with or without disseminated intravascular coagulation","volume":"4","author":"Kienast","year":"2006","journal-title":"J. Thromb. Haemost."},{"key":"10.1016\/j.thromres.2025.109302_bb0040","doi-asserted-by":"crossref","first-page":"505","DOI":"10.1007\/s00134-016-4225-7","article-title":"Antithrombin III for critically ill patients: a systematic review with meta-analysis and trial sequential analysis","volume":"42","author":"Allingstrup","year":"2016","journal-title":"Intensive Care Med."},{"key":"10.1016\/j.thromres.2025.109302_bb0045","doi-asserted-by":"crossref","first-page":"221","DOI":"10.1002\/jhbp.998","article-title":"Clinical impact of recombinant thrombomodulin administration on disseminated intravascular coagulation due to severe acute cholangitis (Recover-AC study)","volume":"30","author":"Ogura","year":"2023","journal-title":"J. Hepatobiliary Pancreat. Sci."},{"key":"10.1016\/j.thromres.2025.109302_bb0050","doi-asserted-by":"crossref","first-page":"508","DOI":"10.1111\/jth.12841","article-title":"Recombinant human soluble thrombomodulin in severe sepsis: a systematic review and meta-analysis","volume":"13","author":"Yamakawa","year":"2015","journal-title":"J. Thromb. Haemost."},{"key":"10.1016\/j.thromres.2025.109302_bb0055","doi-asserted-by":"crossref","first-page":"777","DOI":"10.7326\/M14-2385","article-title":"The PRISMA extension statement for reporting of systematic reviews incorporating network meta-analyses of health care interventions: checklist and explanations","volume":"162","author":"Hutton","year":"2015","journal-title":"Ann. Intern. Med."},{"key":"10.1016\/j.thromres.2025.109302_bb0060","doi-asserted-by":"crossref","DOI":"10.1136\/bmj.d5928","article-title":"The Cochrane Collaboration\u2019s tool for assessing risk of bias in randomised trials","volume":"343","author":"Higgins","year":"2011","journal-title":"Bmj"},{"key":"10.1016\/j.thromres.2025.109302_bb0065","doi-asserted-by":"crossref","first-page":"31","DOI":"10.1111\/j.1538-7836.2006.02267.x","article-title":"Efficacy and safety of recombinant human soluble thrombomodulin (ART-123) in disseminated intravascular coagulation: results of a phase III, randomized, double-blind clinical trial","volume":"5","author":"Saito","year":"2007","journal-title":"J. Thromb. Haemost."},{"key":"10.1016\/j.thromres.2025.109302_bb0070","doi-asserted-by":"crossref","first-page":"349","DOI":"10.1097\/SHK.0b013e318204c019","article-title":"Thrombomodulin alfa in the treatment of infectious patients complicated by disseminated intravascular coagulation: subanalysis from the phase 3 trial","volume":"35","author":"Aikawa","year":"2011","journal-title":"Shock"},{"key":"10.1016\/j.thromres.2025.109302_bb0075","doi-asserted-by":"crossref","DOI":"10.3390\/jcm8101553","article-title":"Human soluble recombinant thrombomodulin, ART-123, resolved early phase coagulopathies, but did not significantly alter the 28 day outcome in the treatment of DIC associated with infectious systemic inflammatory response syndromes","volume":"8","author":"Mori","year":"2019","journal-title":"J. Clin. Med."},{"key":"10.1016\/j.thromres.2025.109302_bb0080","doi-asserted-by":"crossref","first-page":"2069","DOI":"10.1097\/CCM.0b013e31828e9b03","article-title":"A randomized, double-blind, placebo-controlled, phase 2b study to evaluate the safety and efficacy of recombinant human soluble thrombomodulin, ART-123, in patients with sepsis and suspected disseminated intravascular coagulation","volume":"41","author":"Vincent","year":"2013","journal-title":"Crit. Care Med."},{"key":"10.1016\/j.thromres.2025.109302_bb0085","doi-asserted-by":"crossref","first-page":"882","DOI":"10.1378\/chest.104.3.882","article-title":"Double-blind, placebo-controlled trial of antithrombin III concentrates in septic shock with disseminated intravascular coagulation","volume":"104","author":"Fourrier","year":"1993","journal-title":"Chest"},{"key":"10.1016\/j.thromres.2025.109302_bb0090","doi-asserted-by":"crossref","first-page":"R297","DOI":"10.1186\/cc13163","article-title":"A randomized, controlled, multicenter trial of the effects of antithrombin on disseminated intravascular coagulation in patients with sepsis","volume":"17","author":"Gando","year":"2013","journal-title":"Crit. Care"},{"key":"10.1016\/j.thromres.2025.109302_bb0095","doi-asserted-by":"crossref","first-page":"518","DOI":"10.1111\/jth.13230","article-title":"Efficacy and safety of anticoagulant therapy in three specific populations with sepsis: a meta-analysis of randomized controlled trials","volume":"14","author":"Umemura","year":"2016","journal-title":"J. Thromb. Haemost."},{"key":"10.1016\/j.thromres.2025.109302_bb0100","doi-asserted-by":"crossref","DOI":"10.1073\/pnas.2022248118","article-title":"Thrombomodulin is essential for maintaining quiescence in vascular endothelial cells","volume":"118","author":"Giri","year":"2021","journal-title":"Proc. Natl. Acad. Sci. USA"},{"key":"10.1016\/j.thromres.2025.109302_bb0105","doi-asserted-by":"crossref","first-page":"103","DOI":"10.1182\/blood.2019002973","article-title":"Assembly of alternative prothrombinase by extracellular histones initiates and disseminates intravascular coagulation","volume":"137","author":"Abrams","year":"2021","journal-title":"Blood"},{"key":"10.1016\/j.thromres.2025.109302_bb0110","doi-asserted-by":"crossref","first-page":"2255","DOI":"10.1056\/NEJMra2026131","article-title":"Cytokine storm","volume":"383","author":"Fajgenbaum","year":"2020","journal-title":"N. Engl. J. Med."},{"key":"10.1016\/j.thromres.2025.109302_bb0115","doi-asserted-by":"crossref","first-page":"3142","DOI":"10.1111\/jth.15052","article-title":"Anticoagulant and signaling functions of antithrombin","volume":"18","author":"Rezaie","year":"2020","journal-title":"J. Thromb. Haemost."},{"key":"10.1016\/j.thromres.2025.109302_bb0120","first-page":"C98","article-title":"Antithrombin reduces leukocyte adhesion during chronic endotoxemia by modulation of the cyclooxygenase pathway","volume":"279","author":"Hoffmann","year":"2000","journal-title":"Am. J. Phys. Cell Phys."},{"key":"10.1016\/j.thromres.2025.109302_bb0125","doi-asserted-by":"crossref","DOI":"10.3390\/ijms22084283","article-title":"Antithrombin and its role in host defense and inflammation","volume":"22","author":"Schl\u00f6mmer","year":"2021","journal-title":"Int. J. Mol. Sci."},{"key":"10.1016\/j.thromres.2025.109302_bb0130","doi-asserted-by":"crossref","first-page":"897","DOI":"10.1016\/j.thromres.2015.03.007","article-title":"The usefulness of antithrombin activity monitoring during antithrombin supplementation in patients with sepsis-associated disseminated intravascular coagulation","volume":"135","author":"Iba","year":"2015","journal-title":"Thromb. Res."},{"key":"10.1016\/j.thromres.2025.109302_bb0135","doi-asserted-by":"crossref","first-page":"95","DOI":"10.1186\/s13054-021-03524-6","article-title":"Endotheliopathy in septic conditions: mechanistic insight into intravascular coagulation","volume":"25","author":"Ito","year":"2021","journal-title":"Crit. Care"},{"key":"10.1016\/j.thromres.2025.109302_bb0140","doi-asserted-by":"crossref","first-page":"1869","DOI":"10.1001\/jama.286.15.1869","article-title":"Caring for the critically ill patient. High-dose antithrombin III in severe sepsis: a randomized controlled trial","volume":"286","author":"Warren","year":"2001","journal-title":"JAMA"},{"key":"10.1016\/j.thromres.2025.109302_bb0145","doi-asserted-by":"crossref","first-page":"285","DOI":"10.1097\/01.CCM.0000194731.08896.99","article-title":"High-dose antithrombin III in the treatment of severe sepsis in patients with a high risk of death: efficacy and safety","volume":"34","author":"Wiedermann","year":"2006","journal-title":"Crit. Care Med."},{"key":"10.1016\/j.thromres.2025.109302_bb0150","doi-asserted-by":"crossref","first-page":"1470","DOI":"10.1111\/jth.12643","article-title":"Antithrombin and mortality in severe pneumonia patients with sepsis-associated disseminated intravascular coagulation: an observational nationwide study","volume":"12","author":"Tagami","year":"2014","journal-title":"J. Thromb. Haemost."},{"key":"10.1016\/j.thromres.2025.109302_bb0155","doi-asserted-by":"crossref","first-page":"209","DOI":"10.1186\/cc4822","article-title":"Clinical review: molecular mechanisms underlying the role of antithrombin in sepsis","volume":"10","author":"Wiedermann","year":"2006","journal-title":"Crit. Care"},{"key":"10.1016\/j.thromres.2025.109302_bb0160","doi-asserted-by":"crossref","first-page":"34","DOI":"10.1186\/1423-0127-19-34","article-title":"The role of thrombomodulin lectin-like domain in inflammation","volume":"19","author":"Li","year":"2012","journal-title":"J. Biomed. Sci."},{"key":"10.1016\/j.thromres.2025.109302_bb0165","doi-asserted-by":"crossref","first-page":"107","DOI":"10.1007\/s00281-011-0282-8","article-title":"Thrombomodulin and its role in inflammation","volume":"34","author":"Conway","year":"2012","journal-title":"Semin. Immunopathol."},{"key":"10.1016\/j.thromres.2025.109302_bb0170","doi-asserted-by":"crossref","first-page":"280","DOI":"10.1186\/s13054-019-2552-0","article-title":"Thrombomodulin in disseminated intravascular coagulation and other critical conditions-a multi-faceted anticoagulant protein with therapeutic potential","volume":"23","author":"Ito","year":"2019","journal-title":"Crit. Care"},{"key":"10.1016\/j.thromres.2025.109302_bb0175","doi-asserted-by":"crossref","first-page":"4","DOI":"10.1111\/j.1538-7836.2008.03220.x","article-title":"New insights into the molecular mechanisms of the fibrinolytic system","volume":"7","author":"Rijken","year":"2009","journal-title":"J. Thromb. Haemost."},{"key":"10.1016\/j.thromres.2025.109302_bb0180","doi-asserted-by":"crossref","first-page":"1993","DOI":"10.1001\/jama.2019.5358","article-title":"Effect of a recombinant human soluble thrombomodulin on mortality in patients with sepsis-associated coagulopathy: the SCARLET Randomized Clinical Trial","volume":"321","author":"Vincent","year":"2019","journal-title":"JAMA"},{"key":"10.1016\/j.thromres.2025.109302_bb0185","doi-asserted-by":"crossref","first-page":"34","DOI":"10.1038\/nri3345","article-title":"Thrombosis as an intravascular effector of innate immunity","volume":"13","author":"Engelmann","year":"2013","journal-title":"Nat. Rev. Immunol."},{"key":"10.1016\/j.thromres.2025.109302_bb0190","doi-asserted-by":"crossref","first-page":"72","DOI":"10.1186\/s13054-015-0735-x","article-title":"Local hemostasis, immunothrombosis, and systemic disseminated intravascular coagulation in trauma and traumatic shock","volume":"19","author":"Gando","year":"2015","journal-title":"Crit. Care"},{"key":"10.1016\/j.thromres.2025.109302_bb0195","first-page":"848","article-title":"Outcome of disseminated intravascular coagulation in relation to the score when treatment was begun","volume":"74","author":"Wada","year":"1995","journal-title":"Mie DIC Study Group. Thromb Haemost"}],"container-title":["Thrombosis Research"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0049384825000519?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0049384825000519?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,4,25]],"date-time":"2025-04-25T05:49:57Z","timestamp":1745560197000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0049384825000519"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,5]]},"references-count":39,"alternative-id":["S0049384825000519"],"URL":"https:\/\/doi.org\/10.1016\/j.thromres.2025.109302","relation":{},"ISSN":["0049-3848"],"issn-type":[{"value":"0049-3848","type":"print"}],"subject":[],"published":{"date-parts":[[2025,5]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Efficacy and safety of antithrombin or recombinant human thrombomodulin in the treatment of disseminated intravascular coagulation: A systematic review and meta-analysis","name":"articletitle","label":"Article Title"},{"value":"Thrombosis Research","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.thromres.2025.109302","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2025 Elsevier Ltd. All rights are reserved, including those for text and data mining, AI training, and similar technologies.","name":"copyright","label":"Copyright"}],"article-number":"109302"}}